Updated:
AlayaCare
AlayaCare serves 700-plus home-based care agencies with a vertical SaaS platform covering scheduling, clinical documentation, and billing.
AlayaCare
The firm builds and maintains a specialized software platform for agencies delivering care outside institutional walls — spanning home care, home health, and infusion services. Its product consolidates intake, scheduling, care management, billing, payroll, and clinical documentation into a single desktop and mobile environment, with an announced AI assistant branded as Layla and a newer agent-based automation layer called AlayaFlow. Deployment evidence suggests an operational focus on agency profitability and compliance risk rather than speculative R&D, with case studies and support infrastructure geared toward mitigating caregiver churn and billing leakage. While the company does not publish a fund structure or asset-class mix, its go-to-market motion — direct sales teams in North America and Australia/New Zealand, paired with a 700-customer reference base — indicates capital deployment concentrated inside the operating company itself, not a diversified portfolio of third-party bets. The business maintains nine offices split across North America and Australia, with dedicated regional sales lines. No adjacent investment vehicles, philanthropic foundations, or co-investor clubs have been disclosed publicly. As of the firm's own 2025 communications, new AI features are the current product emphasis, including a published guide on AI agents for home-based care. The structural distinction here is the firm's identity as a pure operating company rather than an investment entity. Capital is deployed exclusively into building the AlayaCare software stack and distributing it to care providers — no outside portfolio, no fund commitments, and no reported co-investor architecture. This operating-business posture means any allocator evaluating the firm would underwrite the enterprise value of the SaaS platform itself, not a diversified set of assets.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
Toronto, Canada
Additional offices
Australia · New Zealand
Sector focus
Frequently asked questions
What does AlayaCare's product actually do for a home care agency?
It replaces fragmented back-office and point-of-care tools with one cloud-based system that handles intake, scheduling, care management, billing, payroll, and clinical documentation. The platform is used across home care, home health, and infusion agencies and includes mobile access for field staff. As of 2025, the firm has layered on an AI assistant (Layla) and a workflow-automation agent layer branded AlayaFlow.
Is AlayaCare an investment firm or an operating business?
It operates as a pure software company, not an investment or holding entity. All disclosed capital is deployed into developing and distributing its platform; there is no public evidence of a fund structure, a portfolio of third-party investments, or participation in co-investment vehicles. Underwriting the firm means evaluating a vertical SaaS enterprise, not a diversified asset pool.
Which geographies does AlayaCare serve?
The company operates dual go-to-market hubs: North America (sales and support out of multiple offices in the US and Canada) and Australia/New Zealand, where it maintains a separate sales line and local offices. Its website lists nine office locations split across those two regions.
What types of care providers does AlayaCare target?
It targets agencies across the home-based care continuum — non-medical home care, skilled home health, and infusion therapy providers — as well as palliative care teams. The platform is built to handle the distinct documentation, routing, and billing requirements of each service line.
Does AlayaCare disclose any financial backers or investment structure?
No. The firm has not publicly disclosed a cap table, AUM, or deployment figures, nor does it describe an investment committee or portfolio. Its public-facing materials frame the entity entirely as a product company with a customer count as its primary scale metric.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: